If you're looking for stocks that can make dramatic movements in a short time frame, the biotechnology space has what you ...

Sarepta Therapeutics shares traded lower in premarket trade on Tuesday, as the drugmaker relented to a Food and Drug ...

The French pharma will pay $1.15 billion upfront to buy Vicebio and gain access to non-mRNA vaccine candidates against RSV, ...

Eli Lilly, Summit Therapeutics, and Vertex Pharmaceuticals all have important ongoing clinical trials. Shares of these ...

Sun Pharmaceutical Industries Ltd. closed 14.39% below its 52-week high of 1,960.20 rupees, which the company reached on September 30th.

French pharmaceuticals company Sanofi said on Tuesday it would acquire British private biotechnology firm Vicebio for a total ...

SciSparc Ltd. ("SciSparc" or the "Company") (Nasdaq: SPRC), a specialty clinical-stage pharmaceutical company focusing on the development of therapies to treat ...

DBV Technologies Announces Appointment of James Briggs as Chief Human Resources Officer DBV Technologies (Euronext: DBV - ISIN: FR0010417345 - Nasdaq Market: DBVT) ...

Tesla, Inc.'s declining fundamentals and unsustainable valuation signal risk. Click for key TSLA challenges and why a Strong ...

Check out our earnings calendar for this week, as well as our previews and recaps of the more noteworthy reports.

Lockheed Reports Earnings at a Tough Time. Drones and Defense Budgets Are a Worry. For the quarter, Wall Street is looking for earnings per share of about $6.41 from sales of $18.5 billion, according ...

HOLON, Israel I July 21, 2025 I Compugen Ltd. (Nasdaq: CGEN) (TASE: CGEN), a clinical-stage cancer immunotherapy company and a pioneer in predictive ...